Healis Therapeutics

Healis Therapeutics is a privately held biotechnology company developing a new class of neuromuscular therapies for psychiatry. Healis Therapeutics has acquired ownership of key botulinum toxin patents: IP accelerates the development of botulinum toxin as a candidate drug for treating major depressive disorder (MDD).